HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeted Therapy for Mutation-Driven Metastatic Non-Small-Cell Lung Cancer: Considerations for ALK-Rearranged Tumors.

AuthorsKathryn F Mileham, Mufti N Ahmad, Edward S Kim
JournalOncology (Williston Park, N.Y.) (Oncology (Williston Park)) Vol. 33 Issue 4 Pg. 152-5 (Apr 15 2019) ISSN: 0890-9091 [Print] United States
PMID30990569 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Carbazoles
  • Piperidines
  • Programmed Cell Death 1 Receptor
  • Protein Kinase Inhibitors
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases
  • alectinib
Topics
  • Anaplastic Lymphoma Kinase (genetics)
  • Carbazoles (therapeutic use)
  • Carcinoma, Non-Small-Cell Lung (drug therapy, pathology)
  • Gene Rearrangement
  • Genes, erbB-1 (genetics)
  • Humans
  • Lung Neoplasms (pathology)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Piperidines (therapeutic use)
  • Programmed Cell Death 1 Receptor (antagonists & inhibitors)
  • Protein Kinase Inhibitors (therapeutic use)
  • Receptor Protein-Tyrosine Kinases (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: